Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

I-152

Home DrugsI-152

I-152

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Vaccine constructs and uses thereof against Staphylococcus infections
US 11324815 B2Applicant: SOCPRA SCIENCES ET GENIE SECPriority: 2016
CN
US
2 publications
Tolerogenic peptides from myelin basic protein
US 7071297 B2Applicant: APITOPE TECHNOLOGY BRISTOL LTDPriority: 2002
US
2 publications
Quinoline derivatives for use as intermediates in the synthesis of heterocyclylalcoyl piperidines
EP 1695964 A1Applicant: NOVEXELPriority: 2001
EP
GLUCOSE SENSOR
US 2012232251 A1Applicant: PICKUP JOHNPriority: 2009
US
Anti-hypertension active peptide The-The-Pro, application thereof, and medicinal composition
CN 107337710 AApplicant: YANCHENG INST HEALTH SCIENCEPriority: 2017
CN
Oxazole derivative as well as preparation method and application thereof to pain
CN 109053714 AApplicant: LI JINGJINGPriority: 2018
CN
Injection with HDAC (histone deacetylase) inhibitory activity as well as preparation method and application thereof
CN 115737549 AApplicant: BEIJING XINKAIYUAN PHARMACEUTICALS CO LTDPriority: 2022
CN